✦ LIBER ✦

356 Cost-Effectiveness of Screening for Recurrent Hepatocellular Carcinoma (HCC) After Liver Transplant (LT)

✍ Scribed by Ladabaum, Uri; Cheng, Shan L.; Yao, Francis Y.; Roberts, John P.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness of screening for recu

✍ Uri Ladabaum; Shan L. Cheng; Francis Y. Yao; John P. Roberts 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 527 KB

26 Liver transplantation for hepatocellu

✍ S. Gianni; F.V. Mirante; R. Fassati; D. Forti; V. Mazzaferro; U. Cillo; A. Maffe 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 157 KB

Sorafenib for recurrence of hepatocellul

✍ Arndt Weinmann; Ina Maria Niederle; Sandra Koch; Maria Hoppe-Lotichius; Michael 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 237 KB

Risk-Based Long-Term Screening for Hepat

✍ Hwang, S.; Moon, D.-B.; Ahn, C.-S.; Kim, K.-H.; Ha, T.-Y.; Song, G.-W.; Jung, D. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 991 KB

High toxicity of sorafenib for recurrent

✍ Katharina Staufer; Lutz Fischer; Barbara Seegers; Eik Vettorazzi; Bjoern Nashan; 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 99 KB

Sorafenib for the Treatment of Recurrent

✍ Vitale, A.; Boccagni, P.; Kertusha, X.; Zanus, G.; D'Amico, F.; Lodo, E.; Pastor 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 164 KB